Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Sunshine Biopharma (SBFM) Shares Outstanding (2016 - 2025)

Sunshine Biopharma (SBFM) has disclosed Shares Outstanding for 14 consecutive years, with $4.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding rose 3404.57% year-over-year to $4.6 million, compared with a TTM value of $4.6 million through Sep 2025, up 3404.57%, and an annual FY2024 reading of $130000.0, up 827.78% over the prior year.
  • Shares Outstanding was $4.6 million for Q3 2025 at Sunshine Biopharma, roughly flat from $4.6 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $510.1 million in Q3 2021 and bottomed at $10000.0 in Q1 2022.
  • Average Shares Outstanding over 5 years is $29.0 million, with a median of $1.0 million recorded in 2021.
  • The sharpest move saw Shares Outstanding crashed 99.86% in 2023, then surged 11605.1% in 2024.
  • Year by year, Shares Outstanding stood at $1.0 million in 2021, then plummeted by 99.0% to $10000.0 in 2022, then skyrocketed by 40.12% to $14012.0 in 2023, then surged by 827.78% to $130000.0 in 2024, then soared by 3404.57% to $4.6 million in 2025.
  • Business Quant data shows Shares Outstanding for SBFM at $4.6 million in Q3 2025, $4.6 million in Q2 2025, and $130000.0 in Q1 2025.